Skip to content

Effect of Baclofen Treatment on Nocturnal Muscle Cramps in Patients With Lumbar Spinal Stenosis: a Randomized Clinical Trial

Effect of Baclofen Treatment on Nocturnal Muscle Cramps in Patients With Lumbar Spinal Stenosis: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05392361
Enrollment
40
Registered
2022-05-26
Start date
2022-06-09
Completion date
2023-03-24
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spinal Stenosis With Nocturnal Calf Cramps

Keywords

baclofen, spinal stenosis, nocturnal calf cramps

Brief summary

Nocturnal calf cramps is a common complaint in patients with lumbar spinal stenosis. The purpose of this study is to evaluate the effect of baclofen in lumbar spinal stenosis patients receiving conservative therapy. We will compare pain score, insomnia severity, functional ability and patient satisfaction between control (conservative management for spinal stenosis) and baclofen group (conservative management for spinal stenosis plus baclofen treatment).

Interventions

DRUGgabapentin (neurontin® capsule 300mg) treatment

Taking gabapentin (neurontin® capsule 300mg, Pfizer) medication at night as a conservative treatment

DRUGbaclofen (baclofen Tab. 10mg) treatment

Taking baclofen (baclofen Tab. 10mg, Handok co, Seoul, Korea) medication at night.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. diagnosed lumbar spinal stenosis with MRI finding 2. nocturnal calf cramps symptoms at least once per week

Exclusion criteria

1. electrolyte disorder 2. congenital muscle disease 3. muscle cramps related medication (statins, diuretics, calcium channel blockers, anticonvulsants etc.) 4. cognitive impairments

Design outcomes

Primary

MeasureTime frameDescription
Pain scorefollow up 4 weeksA comparison of pain score between control (conservative management for spinal stenosis) and baclofen group (conservative management for spinal stenosis plus baclofen treatment). The pain score will be measured using NRS (Numeric Rating Scale) on a scale from 0-10, with 0 representing no pain and 10 worst possible pain.

Secondary

MeasureTime frameDescription
Frequency and severity of nocturnal calf crampsfollow up 4 weeks, 12 weeksThe frequency(number) and the severity of nocturnal calf cramps that occurred in a week before each time frame will be investigated. The severity of nocturnal calf cramps will be measured by 0-4 point scale (0, no pain; 1, mild pain that disappeared immediately and tolerable; 2, moderate pain accompanied by pain enough to wake up from sleep; 3, severe pain accompanied by pain enough to wake up from sleep for a long time; 4, severe pain that lasted for a long time and affected a daily life of the next day)
Insomnia severity indexfollow up 4 weeks, 12 weeks
Oswestry Disability Indexfollow up 4 weeks, 12 weeks
Patient satisfaction (PGIC)follow up 4 weeks, 12 weeksPatient satisfaction with treatment at 12 weeks after treatment will be measured by 7-point Patient Global Impression of Change (PGIC; 1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; 7, very much worse)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026